AI assistant
Sending…
Anterix Inc. — Director's Dealing 2022
May 19, 2022
33018_dirs_2022-05-19_c3ab4ff9-ec98-418c-969d-d4b24926bd54.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Anterix Inc. (ATEX)
CIK: 0001304492
Period of Report: 2022-05-17
Reporting Person: Ashe Gena L (Chief Legal Officer & Corp Sec)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2022-05-17 | Common Stock | A | 9112 | $0.00 | Acquired | 42811 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2022-05-17 | Stock Option (Right to Buy) | $49.39 | A | 18368 | Acquired | 2032-05-17 | Common Stock (18368) | Direct |
Footnotes
F1: Represents the issuance of restricted stock units (the "RSUs"). 25% of the RSUs vest and become exercisable on May 17, 2023, with the remaining RSUs vesting in 3 equal annual installments thereafter.
F2: 25% of the option shares vest and become exercisable on May 17, 2023, with the remaining option shares vesting in 3 equal annual installments thereafter.
More from Anterix Inc.
Regulatory Filings
2026
Apr 21
Regulatory Filings
2026
Apr 21
Regulatory Filings
2026
Apr 6
Regulatory Filings
2026
Apr 1
Regulatory Filings
2026
Feb 11
Interim / Quarterly Report
2026
Feb 11
Regulatory Filings
2026
Feb 2
Major Shareholding Notification
2026
Jan 30
Regulatory Filings
2026
Jan 7
Director's Dealing
2025
Dec 19